Stonepine-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
66
Total Value
102762727
Accession Number
0000935836-25-000328
Form Type
13F-HR
Manager Name
Stonepine-Capital-Management
Data Enrichment
92% identified
61 identified5 unidentified

Holdings

66 positions
Manager:
Search and click to pin securities to the top
Page 1 of 4
Evolus, Inc.
Shares:1.1M
Value:$13.6M
ANI PHARMACEUTICALS INC
Shares:48.0K
Value:$13.6M
OptiNose, Inc.
Shares:788.6K
Value:$7.2M
488445206
Shares:650.0K
Value:$4.9M
Verastem, Inc.
Shares:613.0K
Value:$3.7M
UroGen Pharma Ltd.
Shares:333.4K
Value:$3.7M
Surrozen, Inc./DE
Shares:285.8K
Value:$3.3M
ENANTA PHARMACEUTICALS INC
Shares:590.7K
Value:$3.3M
Anika Therapeutics, Inc.
Shares:206.6K
Value:$3.3M
ESTABLISHMENT LABS HOLDINGS INC.
Shares:74.5K
Value:$3.0M
Aquestive Therapeutics, Inc.
Shares:200.0K
Value:$3.0M
INDIVIOR PLC
Shares:304.0K
Value:$2.9M
Day One Biopharmaceuticals, Inc.
Shares:348.8K
Value:$2.8M
Aclaris Therapeutics, Inc.
Shares:527.8K
Value:$2.8M
XOMA Royalty Corp
Shares:129.8K
Value:$2.6M
TELA Bio, Inc.
Shares:2.1M
Value:$2.5M
GALAPAGOS NV
Shares:94.0K
Value:$2.4M
Inhibikase Therapeutics, Inc.
Shares:915.0K
Value:$2.0M
HERON THERAPEUTICS, INC. /DE/
Shares:796.1K
Value:$1.8M
Edesa Biotech, Inc.
Shares:687.5K
Value:$1.7M